Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

BUY
$36.28 - $75.29 $165,327 - $343,096
4,557 New
4,557 $234,000
Q1 2022

Apr 27, 2022

SELL
$69.73 - $142.9 $143,434 - $293,945
-2,057 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$134.56 - $217.97 $5,920 - $9,590
-44 Reduced 2.09%
2,057 $294,000
Q3 2021

Nov 10, 2021

BUY
$177.8 - $270.58 $373,557 - $568,488
2,101 New
2,101 $436,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Argi Investment Services, LLC Portfolio

Follow Argi Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argi Investment Services, LLC with notifications on news.